SYDNEY, AUSTRALIA, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 ...
Based on the GMP-grade quality management system platform, combined with the production specifications of cell therapy drugs in various countries, we have successfully developed a series of ...
VANCOUVER, March 12, 2019 /CNW/ - Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics" or the "Company") a super-premium, organic cannabis producer with operations in Canada, Washington ...
Pheast Therapeutics is using a platform-based approach to scaling manufacturing for its anti-CD24 checkpoint inhibitor, PHST001. By compressing the chemistry, manufacturing, and control (CMC) steps ...
VANCOUVER, BC, March 29, 2021 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis" or the "Company") is pleased to announce that after a competitive bidding process, the Company has executed a binding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback